225 related articles for article (PubMed ID: 25127184)
1. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
Notley C; Blyth A; Maskrey V; Pinto H; Holland R
Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
[TBL] [Abstract][Full Text] [Related]
2. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
3. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
4. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
5. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
6. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
[TBL] [Abstract][Full Text] [Related]
7. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
Richert T; Johnson B
Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
[TBL] [Abstract][Full Text] [Related]
8. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
Notley C; Blyth A; Maskrey V; Craig J; Holland R
Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
[TBL] [Abstract][Full Text] [Related]
9. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma.
Lacroix A; Puybaret V; Villéger P; Zattoni-Leroy J; Cantaloube S; Chevalier C; Nubukpo P
Therapie; 2024; 79(3):307-317. PubMed ID: 37625937
[TBL] [Abstract][Full Text] [Related]
11. Opioid dependence - management in general practice.
Frei M
Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
[TBL] [Abstract][Full Text] [Related]
12. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
15. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
Wachholtz A; Gonzalez G
Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
17. [Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].
Hoffmann O; Frisell F; Ljungberg T
Lakartidningen; 2014 Jan 29-Feb 4; 111(5):147-9. PubMed ID: 24624763
[No Abstract] [Full Text] [Related]
18. Regaining control: the patient experience of supervised compared with unsupervised consumption in opiate substitution treatment.
Notley C; Holland R; Maskrey V; Nagar J; Kouimtsidis C
Drug Alcohol Rev; 2014 Jan; 33(1):64-70. PubMed ID: 24256157
[TBL] [Abstract][Full Text] [Related]
19. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
Johnson B; Richert T
J Addict Dis; 2015; 34(1):1-17. PubMed ID: 25496247
[TBL] [Abstract][Full Text] [Related]
20. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
